Sidovis, Konzentrat zur Herstellung einer Infusionslösung

7680666920015 CH-66692 Konzentrat
Sidovis, Konzentrat zur Herstellung einer Infusionslösung
Sidovis, Konzentrat zur Herstellung einer Infusionslösung
Sidovis, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
06/10/2023
Summary of Product Characteristics
Français
06/10/2023
Summary of Product Characteristics
Italien
06/10/2023

Detailed composition

Substance Quantity Type Category
(N/A)
75.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
11.0 MG Substance HBESI

Authorization holder

IDEOGEN AG

8807 Freienbach

Authorization information

Swissmedic authorization number
66692
Drug name
Sidovis, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOPA
ATC Code
J05AB12
Authorization status
Z
Dispensing category
A
First authorization
20/10/2017
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
Virostatikum

Package details

Description (FR)
SIDOVIS conc perf 375 mg/5ml flac 5 ml
Description (DE)
SIDOVIS Inf Konz 375 mg/5ml Durchstf 5 ml
Market launch
20/10/2017
Narcotic (BTM)
No